Scharstuhl A
|
 |
- 12
Stoop R, Sapei L, Gaissmaier C, Scharstuhl A, Kellomäki M, Ellä V, Ashammakhi N, Törmälä P, Hämmerle H. Evaluation of PLDLA Scaffolds for Cartilage Tissue Engineering. 15th Interdisciplinary Research Conference on Biomaterials (GRIBOI 2005), Shanghai, China, 18-20.3.2005.
- 11
Stoop R, Sapei L, Gaissmaier C, Scharstuhl A, Kellomäki M, Ellä V, Ashammakhi N, Törmälä P, Hämmerle H. Investigation of PLDLA Scaffolds for Cartilage TE. University of Oulu Faculty of Medicine Science Day, Oulu, Finland, February 22, 2005. P-28.
|
|
- 10
Scharstuhl A, van Beuningen H.M, Vitters E.L,
Lieuwes N, van der Kraan P.M, van den Berg W.B.
Shifted expression profiles of various TGF-b signaling
mediators in chondrocytes of young compared to old
mice. Submitted.
- 9
Scharstuhl A, Glansbeek H, Vitters E, van der Kraan P, van den Berg W. Blocking of endogenous Transforming
Growth Factor-b during experimental osteoarthritis
prevents osteophyte formation and decreases cartilage
proteoglycan content. Inflammation Research. 2003.
In press.
- 8
Scharstuhl A, Diepens R, Lensen J, van Beuningen H,
Vitters E, van der Kraan P and van den Berg W.Adenoviral
overexpression of Smad7 and Smad6 differentially antagonize
TGF-b activity in chondrocytes”. 2003. Conditionally
accepted by Osteoarthritis & Cartilage.
- 7
Scharstuhl A, Vitters E, van der Kraan P, van den Berg W. Adenoviral overexpression of TGF-b/BMP inhibitors
during experimental osteoarthritis reduces osteophyte
formation and synovial thickness. Conditionally accepted
by Arthritis & Rheumatism.
|
|
- 6
Stoop R, Sapei L, Gaissmaier C, Scharstuhl A, Kellomäki
M, Ellä V, Ashammakhi N, Törmälä
P, Hämmrele H. The Development of Woven P(L/D)LA
Scaffolds for Cartilage Tissue Engineering. 18th European
Conference on Biomaterials, October 1-4, 2003, Stuttgart,
Germany.
-
5
Scharstuhl A, Glansbeek H, Vitters E, van der Kraan P, van den Berg W. Large scale protein production
of the extracellular domain of the Transforming Growth
Factor-b type II receptor via the Pichia pastoris
expression system. Journal of Chromatography B. 2003.
786:271-277.
|
|
- 4
Scharstuhl A, Glansbeek H, van Beuningen H, Vitters E, van der Kraan P and van den Berg W. Inhibition
of endogenous TGF-b during experimental osteoarthritis
prevents osteophyte formation and impairs cartilage
repair. Journal of Immunology. 2002. 169: 507-514.
- 3
Scharstuhl A, van Beuningen H, Vitters E, van der Kraan P and van den Berg W. Loss of TGF-b counteraction
on IL-1-mediated effects in cartilage of old mice.
Annals of the Rheumatic Diseases. 2002. 61: 1095-1098.
- 2
van den Berg W.B, van der Kraan P.M, Scharstuhl A,
van Beuningen H.M, Bakker A, van Lent P.L.E.M, F.
van de Loo A.J.
Dualistic role of TGF-b in osteoarthritis cartilage
destruction and osteophyte formation. In The many
faces of Osteoarthritis V. C. Hascall and K. E. Kuettner,
Editors. 2002. pp 261-265
|
|
-
1
van den Berg W, van der Kraan P, Scharstuhl A, van Beuningen H. Growth factors and cartilage repair.
Clinical Orthopaedics and Related Research. 2001.
391S, S244-S250.
|
|
